← Back to Search

1 for Swallowing Disorders (EEsAI Trial)

N/A
Waitlist Available
Led By Alain Schoepfer, MD, PD+MER1
Research Sponsored by University Hospital Inselspital, Berne
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Summary

Eosinophilic Esophagitis (EoE) is a chronic inflammatory disease of the esophagus affecting children and adults. The most frequent symptoms are swallowing difficulties and thoracic pain. The disease has first been described in the 1980s and is found with rapidly increasing frequency mainly in industrialized countries. The factors that lead to EoE are until now incompletely understood, of importance, the disease is found more frequently in men and patients suffering from allergic diseases (e.g., Asthma). So far there exists no activity index to define the severity of EoE; such an index is urgently needed for future clinical trials to determine the efficacy of current and future therapies. The investigators' 3-year project, carried out in cooperation with international EoE experts, aims at the development of an activity index for adult and pediatric EoE patients that will be used in future clinical trials as well as observational studies.

Eligible Conditions
  • Swallowing Disorders
  • Esophageal Diseases
  • Eosinophilia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Trial Design

2Treatment groups
Experimental Treatment
Group I: 2Experimental Treatment1 Intervention
cohorts 2 (evaluation phase): 200 children with Eosinophilic Esophagitis, 200 adults with Eosinophilic Esophagitis
Group II: 1Experimental Treatment1 Intervention
cohorts 1 (item weighting phase): 100 children with Eosinophilic Esophagitis, 150 adults with Eosinophilic Esophagitis

Find a Location

Who is running the clinical trial?

Northwestern UniversityOTHER
1,625 Previous Clinical Trials
936,639 Total Patients Enrolled
Kantonsspital OltenOTHER
11 Previous Clinical Trials
4,010 Total Patients Enrolled
University of CincinnatiOTHER
433 Previous Clinical Trials
635,753 Total Patients Enrolled
~44 spots leftby Sep 2025